JournalsHub
.online
Find My Journal
SM

Sven Mahner

Universität Hamburg DE

ORCID iD 0000-0002-0640-129X
327
Publications
8,014
Citations
37
H-Index
104
i10-Index
0.83
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

326 total

European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023 PDF

Maaike H.M. Oonk, François Planchamp, Peter Baldwin, Sven Mahner, Mansoor Raza Mirza et al. - International Journal of Gynecological Cancer, 2023
Cited by 190 OpenAlex

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens, Antonio González-Martı́n, Leslie M. Randall et al. - The Lancet Oncology, 2021
Cited by 377 OpenAlex

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial PDF

Josep M. del Campo, Ursula A. Matulonis, Susanne Malander, Diane Provencher, Sven Mahner et al. - Journal of Clinical Oncology, 2019
Cited by 189 OpenAlex

Safety and dose modification for patients receiving niraparib

Jonathan S. Berek, Ursula A. Matulonis, Ulla Peen, Prafull Ghatage, Sven Mahner et al. - Annals of Oncology, 2018
Cited by 185 OpenAlex

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer PDF

Maaike H.M. Oonk, François Planchamp, Peter Baldwin, Mariusz Bidziński, Mats Brännström et al. - International Journal of Gynecological Cancer, 2017
Cited by 195 OpenAlex

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer PDF

Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt, Amit M. Oza, Sven Mahner et al. - New England Journal of Medicine, 2016
Cited by 2,431 OpenAlex

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

Amit M. Oza, David Cibula, Ana Oaknin Benzaquen, Christopher Poole, Ron H.J. Mathijssen et al. - The Lancet Oncology, 2014
Cited by 541 OpenAlex

Research Topics

Ovarian cancer diagnosis and treatment (49) PARP inhibition in cancer therapy (36) Estrogen and related hormone effects (31) Cancer Cells and Metastasis (24) Reproductive System and Pregnancy (24)

Affiliations

Gynecologic Oncology Group
US 2010 - 2010
Harvard University
US 2006 - 2006
Universität Hamburg
DE 2025 - 2007
German Cancer Research Center
DE 2025 - 2023
Heidelberg University
DE 2018 - 2002

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now